Virtu Financial’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32K Buy
+22,717
New +$43.9K ﹤0.01% 1298
2026
Q1
– Sell
-13,702
Closed -$15K – 1589
2025
Q4
$15K Buy
+13,702
New +$20.7K ﹤0.01% 1465

Other funds holding ALXO

Virtu Financial's ALXO Position: Q3 2026 in Review

Virtu Financial opened a new position in ALX Oncology (ALXO) in Q3 2026: 22,717 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ALXO as recently as Q4 2025.

Virtu Financial first reported a position in ALXO in Q4 2025 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Virtu Financial held 22,717 shares of ALX Oncology worth $32K as of Q3 2026.
  • ALX Oncology was a new Virtu Financial position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1298 holding.
  • Virtu Financial first reported a position in ALX Oncology in Q4 2025 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.